Details of the Drug Reposition

General Information of This Drug (ID: DMRWDG9)

• Drug Name: MPC-300-IV (DMRWDG9)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Rheumatoid arthritis	DISTSB4J	FA20	Phase 2	[1]
Diabetic nephropathy	DIS2FCCT	GB61.Z	Phase 2	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)